Zavante Therapeutics

About:

Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.

Twitter/X: zavanteinc

Top Investors: Frazier Healthcare Partners, Longitude Capital, Aisling Capital, Square 1 Bank, Mesa Verde Venture Partners

Description:

Zavante is a clinical-stage biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients.

Total Funding Amount:

$65M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Diego, California, United States

Founded Date:

2015-01-01

Contact Email:

hr(AT)zavante.com

Founders:

Ted Schroeder

Number of Employees:

11-50

Last Funding Date:

2021-01-01

IPO Status:

Private

Industries: